1. Cardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?. (3rd October 2022) Authors: Nikolaou, P E; Mylonas, N; Makridakis, M; Makrecka-Kuka, M; Iliou, A; Zerikiotis, S; Efentakis, P; Kostomitsopoulos, N; Vilskersts, R; Zuurbier, C; Latosinska, A; Vlahou, A; Dimitriadis, G; Iliodromitis, E K; Andreadou, I Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗